CRW
NEUTRALCraneware plc Announces Holding(s) in Company
The healthcare software provider has announced a change in shareholding, with Liontrust Investment Partners LLP increasing its stake in the company.
Craneware
1,970.00GBX
1.55%
Market Cap
697.57M
Volume
22.46k
26% of avg
P/E Ratio
16.84
EPS (TTM)
1.17
Beta
0.28
Day Range
1,900.00p - 2,000.00p
52 Week Range
1,495.00p1,970.00p2,509.20p
1,970.00p
Upcoming Events
September 2025
Full Year 2025 Results expected
High Impact Event
CRW
NEUTRALCraneware Chair Purchases Shares
The healthcare software provider has announced that its Chair has purchased additional shares in the company.
CRW
NEUTRALCraneware Announces Dividend Currency Election
The healthcare software provider Craneware has announced details on the currency election for its upcoming interim dividend payment.
CRW
VERY GOODCraneware Reports Record H1 Results with Double-Digit Growth
The healthcare financial performance solutions provider reported record interim results, with double-digit growth in revenue and profits. Strong customer retention and strategic partnerships underpin future growth prospects.
CRW
NEUTRALCraneware Announces Change in Major Shareholding
The healthcare software provider has notified a change in major shareholding, with Aegon Ltd increasing its stake.
CRW
GOODCraneware Delivers Strong H1 FY25 Performance
The healthcare software provider reports robust H1 FY25 results, with double-digit growth in revenue and EBITDA, and continued expansion of its recurring revenue base.
CRW
NEUTRALCraneware Provides Dividend Currency Election Details
Healthcare software provider Craneware announces dividend currency election details.
CRW
NEUTRALCraneware Shareholder Aegon Reduces Stake
Healthcare IT company Craneware sees minor shareholder change
CRW
GOODCraneware Sees Continued Growth Momentum
The healthcare software provider reports continued strong trading performance, with positive momentum expected to drive further growth.
CRW
NEUTRALCraneware Sees Increased Institutional Investor Interest
Healthcare IT company sees modest increase in institutional investor interest